Toxicities of 166Holmium-chitosan in mice

Arzneimittel-Forschung/Drug Research

Volumn 48, Issue 3, 1998, Pages 300-304

  Lee, Won Yong ^a   Moon, Eun Yi ^a   Lee, Jin ^a   Choi, Chung Ha ^a   Nam, Soon Chul ^a   Park, Kyung Bae ^b   Ryu, Jei Man ^a   Chung, Yong Ho ^a   Yoon, Sung June ^a   Lee, Dug Keun ^a  

^a DongWha Pharm Ind Co   (South Korea)

^b Korea Atomic Energy Research Institute   (South Korea)

Author keywords

Chitosan; DW 166HC, toxicity studies; Holmium 166; Radiopharmaceutical; Spleen; White pulp

Indexed keywords

CHITOSAN DERIVATIVE; DW 166HC; HOLMIUM; HOLMIUM 166; HOLMIUM CHITOSAN COMPLEX HO 166; UNCLASSIFIED DRUG; DIAGNOSTIC AGENT; RADIOISOTOPE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL DIVISION; CONTROLLED STUDY; DOSE RESPONSE; DRUG DISTRIBUTION; HYPERSPLENISM; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY MASS; MALE; MOUSE; NONHUMAN; SPLEEN; ANIMAL; BLOOD; BODY WEIGHT; DRUG EFFECT; MOUSE STRAIN; ORGAN SIZE; PATHOLOGY;

ANIMALS; BODY WEIGHT; HOLMIUM; INJECTIONS, INTRAVENOUS; MALE; MICE; MICE, INBRED STRAINS; ORGAN SIZE; RADIOISOTOPES; SPLEEN;

EID: 0032016522     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Turner, J. H., Claringbold, P. G., Klemp, P. F. B. et al., Nucl. Med. Commun. 15, 545 (1994)
2. Parks, N. J., Kawakami, T. G., Avila, M. J. et al., Blood 82, 318 (1993)
3. Dunn, J. K., Doige, C. E., Searcy, G. P. et al., J. Small Anim. Pract. 27, 799 (1986)
4. Turner, J. H., Martindale, A. A., Sorby, P. et al., Eur. J. Nucl. Med. 15, 784 (1989)
5. Larson, S. M., Raubitschek, A., Reynolds, J. C. et al., Nucl. Med. Biol. 16, 153 (1989)
6. Bayouth, J. E., Macey, D. J., Med. Phys. 20, 1089 (1993)
7. Johannsson, O., Perrault, G., Savoie, L. et al., Br. J. Pharmacol. Chemother. 33, 91 (1968)
8. LeHoux, J., Grondin, F., Endocrinology 132, 1078 (1993)
9. Campbell, R. C., Statistics for Biologists, pp. 61-75, Cambridge University Press. Cambridge (1989)
10. Weissman, S. M., Waldmann, T. A., Levin, E. et al., Blood 17, 632 (1961)
11. Levine, S., Gherson, J., Int. J. Immunopharmacol. 8, 999 (1986)
12. Benjamin, S. A., Powers, B. E., Nikula, K. J. et al., in: Handbook of Toxicologic Pathology, W. M. Haschek, C.G. Rousseaux (eds.), pp. 983-1045, Academic Press, New York (1991)
13. Leung, T. W. T, Lau, W., Ho, S. K. W. et al., Int. J. Radiat. Oncol. Biol. Phys. 33, 919 (1995)
14. Landes, D. R., Bough, W. A., Bull. Environ. Contam. Toxicol. 15, 555 (1976)
15. Greaves, P. (ed.), Histopathology of Preclinical Toxicity Studies, pp. 77-142, Elsevier, Amsterdam (1990)
16. Marcinkiewicz, J., Polewska, A., Knapczyk, J., Arch. Immunol. Therp. 39 127 (1991)
17. Nishimura, K., Nishimura, S., Nishi, N. et al., Vaccine 2, 93 (1984)
18. Lee, W. Y., Lee, J., Moon, E. Y. et al., J. Appl. Pharmacol. (Korea) 5, 100 (1997)
19. Siegel, B. V., Morton, J. I., Int. J. Vitam. Nutr. Res. 53, 179 (1983)
20. Haley, T. J., Koste, L., Komesu, N. et al., Toxicol. Appl. Pharmacol. 8, 37 (1966)